Adiponectin Trajectories Before Type 2 Diabetes Diagnosis
Year: 2012
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: The role of adiponectin in the natural history of diabetes is not well characterized. We set out to characterize prediagnosis trajectories of adiponectin in individuals who develop type 2 diabetes. RESEARCH DESIGN AND METHODS: In a case-cohort study (335 incident diabetes case and 2,474 noncase subjects) nested in the Whitehall II study, serum adiponectin was measured up to three times per participant (1991-1993, 1997-1999, and 2003-2004). Multilevel models adjusted for age and ethnicity were fitted to assess 13-year trajectories of log-transformed adiponectin preceding diabetes diagnosis or a randomly selected time point during follow-up (year(0)) based on 755/5,095 (case/noncase) person-examinations. RESULTS: Adiponectin levels were lower in diabetes case than in noncase subjects (median 7,141 [interquartile range 5,187-10,304] vs. 8,818 [6,535-12,369] ng/mL at baseline, P < 0.0001). Control subjects showed a modest decline in adiponectin throughout follow-up (0.3% per year, P < 0.0001) at higher levels in women than in men (difference at year(0): 5,358 ng/mL, P < 0.0001). Female case and early-onset case (age at diagnosis <52 years) subjects had a steeper decline than control subjects (slope difference -1.1% per year, P = 0.001 in females, -1.6% per year in early-onset case subjects, P = 0.034). In men, adiponectin slopes for case and noncase subjects were parallel. The slope differences by diabetes onset were largely attenuated after adjustment for changes in obesity, whereas the sex-specific slope differences were independent of obesity. CONCLUSIONS: Lower adiponectin levels were observed already a decade before the diagnosis of diabetes. The marked sex difference in trajectories suggests that sex-specific mechanisms affect the association between adiponectin levels and diabetes development.
Source: Diabetes Care
DOI: 10.2337/dc11-2263
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: John D. and Catherine T. MacArthur Foundation, National Institute for Health and Care Research, British Heart Foundation, Bupa Foundation, University College London, Health and Safety Executive, Bundesministerium für Gesundheit, Heinrich-Heine-Universität Düsseldorf, National Institutes of Health, Agency for Healthcare Research and Quality, Medical Research Council, Economic and Social Research Council, Leibniz-Gemeinschaft, National Institute on Aging, National Heart, Lung, and Blood Institute
Awards: G2307454678, Determinants of healthy ageing in the Whitehall II study, G4722625316, CHANGES IN HEALTH: SOCIO-ECONOMIC STATUS AND PATHWAYS, Psycho-social and biological factors in the occurrence of cardiovascular disease: The Whitehall II study, Socio-economic status and heterogeneity in aging, Socioeconomic gradient in CHD in early old age
OpenAlex ID: W2169257546
